CapitaLand Group
With a solid business ecosystem, we deliver long-term sustainable value to our stakeholders.
Global
English
CapitaLand Group
With a solid business ecosystem, we deliver long-term sustainable value to our stakeholders.
CapitaLand Group
With a solid business ecosystem, we deliver long-term sustainable value to our stakeholders.
CapitaLand officially opens S$1.4 billion Geneo, marking a key milestone in Singapore Science Park rejuvenation
Global life sciences and innovation tenants at Geneo underscore CapitaLand’s expertise in building differentiated future-ready ecosystems
22 May 2026
Share
(L-R) William Tay, CEO and Executive Director of the Manager at CapitaLand Ascendas REIT; Jonathan Yap, CEO, CapitaLand Development; Dr Tan See Leng, Minister for Manpower and Minister-in-charge of Energy and Science & Technology in the Ministry of Trade and Industry; Mr Wong Kan Seng, Chairman, CapitaLand Group; Ronald Tay, CEO, CapitaLand Development (Singapore) at the official opening of Geneo
Singapore, 22 May 2026 – CapitaLand Group (CapitaLand) today officially opened Geneo, a life sciences and innovation hub at Singapore Science Park (SSP). The opening marks a key milestone in CapitaLand's multiphase rejuvenation of Singapore's first research and development (R&D) and technology park.
Geneo is jointly owned by CapitaLand Development (CLD) and CapitaLand Ascendas REIT (CLAR)1. Totalling about S$1.4 billion in investments, Geneo spans three properties, 1 Science Park Drive, 5 Science Park Drive and 7 Science Park Drive, with a total gross floor area (GFA) of approximately 180,600 square metres (sqm). This includes approximately 80,000 sqm of purpose-built infrastructure for biomedical R&D, flexible laboratories and innovation-ready Grade A business park workspaces.
The opening ceremony was officiated by Dr Tan See Leng, Minister for Manpower and Minister-in-charge of Energy and Science & Technology in the Ministry of Trade and Industry. Other attendees included government agency representatives, SSP tenants and key partners of CapitaLand.
Opening address by Minister Tan See Leng
Minister Tan See Leng viewing the exhibition panels on Geneo's journey
Guests at the official opening of Geneo
Welcome address by Jonathan Yap, CEO of CLD
Jonathan Yap, CEO of CLD, the master developer and park operator of SSP, said: "Geneo is a defining milestone in the rejuvenation of SSP. For over 40 years, the Park has been a cornerstone of Singapore's economic and innovation growth. Drawing on CLD's expertise in delivering differentiated real estate and CapitaLand’s ecosystem, Geneo is a vibrant people-centric development that brings together purpose-built workspaces with curated lifestyle and retail offerings. As a life sciences and innovation hub, it supports the full innovation cycle, from research through to commercialisation, within an integrated environment.”
He added: “Geneo is part of a broader vision for the rejuvenation of SSP. Alongside LyndenWoods2, the upcoming first residential project in SSP, and Citadines Science Park Singapore, the first lodging facility in SSP, there are pipeline plans to add residential developments that will further enliven the precinct. CLD will continue to ideate innovative ways to create more sustainable spaces for SSP communities to further integrate live, work and play.”
William Tay, CEO and Executive Director of the manager of CLAR, said: “Our successful redevelopment of 1 Science Park Drive and acquisition of 5 Science Park Drive underscore CLAR’s proactive portfolio rejuvenation strategy to enhance portfolio resilience with future-ready assets. These high-quality properties are seeing strong tenancy demand from world-leading companies in biomedical sciences, R&D and technology sectors, further reinforcing CLAR’s leadership position in Singapore’s life sciences real estate market. With a portfolio of approximately 4.5 million square feet of properties at Singapore Science Park, CLAR is the largest provider of business park and life sciences space within the precinct.”
William Tay, CEO and Executive Director of the manager of CLAR
World-class tenants anchor Geneo’s life sciences and innovation ecosystem
Geneo has attracted world-class tenants, including Agency for Science, Technology and Research (A*STAR), Barry Callebaut, Chugai Pharmabody Research, Henkel, and NSG Bio, spanning industries from biotech and advanced manufacturing to food innovation, and pharmaceutical R&D. Their presence at Geneo underscores confidence in CapitaLand's capabilities in best-in-class developments that support a wide range of R&D activities and innovation needs. It also reinforces CapitaLand’s role as an ecosystem curator, connecting Singapore-based researchers, start-ups and corporates with global partners, investors as well as institutions.
The specialised infrastructure at Geneo includes wet lab and wet lab-ready floors, coworking laboratory space, units with tailored specifications such as high floor loading, and smart building management systems. There are also communal spaces and active placemaking programmes that encourage cross-disciplinary collaborations.
The life sciences and innovation community at Geneo is further enabled by Bridge+ Geneo. It provides premium flexible workspaces and NSG BioSuites, CapitaLand’s first coworking laboratory facility in partnership with NSG Bio. The facility is Southeast Asia's largest coworking laboratory which spans over 3,200 sqm (nearly 35,000 square feet). Together, they form The Apex, where researchers, start-ups, corporates and investors connect and scale-up. These facilities support a life science enterprise’s full journey from discovery and experimentation to team growth and industry deployment.
Minister Tan See Leng visiting Geneo tenant, NSG Bio.
Minister Tan See Leng visiting Geneo tenant, Barry Callebaut.
Minister Tan See Leng visiting Geneo tenant, Henkel.
The Apex complements The Seed, a genomic garden designed in collaboration with SingHealth Duke-NUS Institute of Biodiversity Medicine, and The Canopy, a 3,000 sqm all-weather event plaza. Inspired by the layers of a forest ecosystem, The Seed represents discovery and growth, while The Canopy brings people and communities together. Rising from this ecosystem, The Apex is the culmination point where ideas, research and innovation converge. Collectively, these spaces create a holistic environment where science, nature, and community intersect.
The Seed is a genomic garden designed in collaboration with SingHealth Duke-NUS Institute of Biodiversity Medicine.
The Canopy is a 3,000 sqm all-weather event plaza where large-scale community and industry events can be held.
Sustainability and community at the core
Geneo achieved the Building and Construction Authority's (BCA) Green Mark Platinum rating for all three properties, including Super Low Energy for 7 Science Park Drive. Both 1 and 7 Science Park Drive also attained International WELL Building Institute's WELL Core Gold Certification for healthy building design. Coupled with SSP’s first distributed district cooling network, energy and water-efficient systems, and smart building technologies, these integrated features help optimise resource efficiency, cater to tenants' sustainability needs, and reinforce CapitaLand's long-term commitments.
As part of its commitment to corporate social responsibility, SSP in partnership with CapitaLand Hope Foundation and Access Singapore will launch the SSP-ACE! (Access Career Exploration) Programme this year. Through mentorship, workplace engagement, and industry-grounded challenge statements, the SSP-ACE! Programme offers students from underserved backgrounds meaningful opportunities to explore STEM3 pathways, while strengthening connections between education, industry and place.
Please refer to the following Annexes for more information or visit https://geneo.sciencepark.com.sg/.
Annex A – Welcome address by Jonathan Yap, CEO of CLD
Annex B – Geneo fact sheet
[1] 1 Science Park Drive comprises three buildings – 1, 1A and 1B. CLD holds a 66% stake in 1 Science Park Drive and fully owns 7 Science Park Drive, while CLAR holds a 34% stake in 1 Science Park Drive and fully owns 5 Science Park Drive.
[2] LyndenWoods is the upcoming first residential project in SSP and one of the best-selling residential projects in Singapore last year; it achieved 94% sales on launch day.
[3] STEM stands for Science, Technology, Engineering, and Mathematics
Overview |
|
Description
|
Geneo is a business park development that offers purpose-built infrastructure conducive for life sciences and innovation companies to thrive. Its name combines “ingenuity” and “gene” to reflect the cluster’s focus on supporting life sciences companies in bringing their innovation to fruition. It can also be read as “Gen Neo” to symbolise the next generation of innovators nurtured through fresh real estate experiences. Geneo is envisioned as a hub that brings researchers, scientists and knowledge workers together to drive impact. The vision is represented through its logo, which features a merging of chromosomes and a spark, and its tagline “Where Ingenuity Comes to Life”. |
Development details
|
Geneo offers about 180,600 sqm of GFA, integrated with work-live-play elements. Comprises three properties with five buildings:
|
Owners |
CapitaLand Development: 1 Science Park Drive (66%), 7 Science Park Drive (100%) CapitaLand Ascendas REIT: 1 Science Park Drive (34%), 5 Science Park Drive (100%) |
Core consultants |
|
Concept Architect |
Serie + Multiply Consultants Pte Ltd. |
Project Architect |
Surbana Jurong Consultants Pte Ltd |
Main Contractor |
Woh Hup (Private) Limited |
Quantity Surveyor |
WT Partnership (S) Pte Ltd |
Mechanical & Electrical Engineer |
Squire Mech Pte Ltd |
Civil & Structural Engineer |
Mott MacDonald Singapore Pte Ltd |
Civil & Structural Engineer (Slip Road) |
T.Y. Lin International Pte Ltd |
Landscape Designer |
Grant Associates Singapore Pte Ltd |
Environmental & Sustainability Design Consultant |
Surbana Jurong Consultants Pte Ltd |
Lighting Designer |
Nipek Pte Ltd |
List of awards |
|
|
|
Agency for Science, Technology and Research (A*STAR)
Dr Lisa Ooi, Assistant Chief Executive, Biomedical Research Council, A*STAR: “Our extension into Geneo is part of A*STAR’s broader effort to renew our research infrastructure for greater real-world impact. By bringing our biomedical research entities closer to key ecosystem partners, including the clinical community and venture builders, we aim to strengthen collaboration and create better conditions for research to translate into economic, health and societal outcomes for Singapore.”
Barry Callebaut
Yeting Liu, Vice President of Cacao Coatings Center of Excellence and Head of R&D in Asia Pacific, Middle East and Africa: “With 30 years of operations in Singapore, Barry Callebaut drives innovation in the chocolate and cocoa industry through advanced food science and applied R&D. Geneo feels like the natural next step as we grow our R&D capabilities. Beyond its world‑class infrastructure and exceptional connectivity, what drew us to Geneo is its vibrant ecosystem, from pioneering startups to leading research institutions. Through the Callebaut Global Innovation Center at Geneo, we bring together customers, scientists and partners to translate research into real‑world solutions and scale them globally from Singapore.”
Chugai Pharmabody Research
Dr. Futa Mimoto, Director and CEO, Chugai Pharmabody Research: “We are delighted to announce our relocation to Geneo at Singapore Science Park. This milestone reflects our commitment to Singapore's world-class life sciences ecosystem. Geneo’s prime location and state-of-the-art facilities will strengthen our collaborations with a diverse range of partners, from academia and biotech start-ups to established industry players. Through these partnerships, we remain dedicated to advancing drug discovery and delivering meaningful contributions to patients together with Singapore's vibrant scientific community.”
Henkel
Thomas Holenia, President of Henkel Singapore: “Our future-ready hub at Geneo brings our Singapore teams together to strengthen Henkel’s innovation and scaling capabilities across Asia Pacific. Being part of a vibrant innovation ecosystem, close to research institutes, universities and the deep tech community, was an important consideration. This new hub enhances our operational agility and enables us to deliver more innovative and sustainable solutions to customers across multiple industries.”
NSG Bio
Hasyim Sim, Chief Operating Officer, NSG Bio: “Geneo is closely aligned with NSG Bio’s long-term growth because it strengthens our ability to support the biotech community in Singapore. As the ecosystem continues to expand, it is critical for infrastructure to evolve alongside the needs of the industry. The new space at Geneo gives us greater flexibility to support companies at different stages of their growth journey, from early-stage startups that are beginning to scale to more established players requiring ready to use Biological Safety Level 2 laboratories. It brings together a strong network of life sciences vendors, global venture capital partners and multinational pharma companies, strengthening Singapore’s position as a leading global life sciences hub.”
